Clinical Trials Sponsored by Kefang Lai

Total 9765 results

Kefang Lai

Not yet recruiting

ATP Level and Cough Sensitivity to ATP in Subjects With Refractory Chronic Cough

Refractory Chronic Cough
Kefang Lai

Unknown

A Study on the Mechanism of Cough Hypersensitivity

Cough

China
Weifang Medical University
Weifang People's Hospital

Recruiting

Effect of Implementing Snap-needle Therapy Combined With Ginger Paste During Anesthesia Recovery on the Recovery of Gastrointestinal Function After Gynecologic Laparoscopy

Postoperative Nausea and Vomiting | Gastrointestinal Motility

China
Yefeng Cai

Unknown

SouthErn China REgisTry for Stroke on Traditional Chinese Medicine (SECRETS-TCM)

Stroke | Transient Ischemic Attack | Cerebral Infarction | Subarachnoid Hemorrhage | Cerebral Hemorrhage

China
Penang Hospital, Malaysia

Unknown

Personalized Mobile Phone Video Recording to Improve Inhaler Techniques in Asthma Patients. (RECORD)

Asthma

Malaysia
Penang Hospital, Malaysia

Completed

Clinical Performance and Safety Comparison of Stay Safe Link® With Stay Safe® in Patient on CAPD (CAPD-3) (CAPD-3)

Continuous Ambulatory Peritoneal Dialysis

Malaysia
Deyang Stomatological Hospital

Unknown

Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach

Maxillary Sinus Disease
Weifang Medical University

Recruiting

Effect of Intravenous 5% Dextrose Infusion During Recovery From Anesthesia on the Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy

Insulin Resistance | Postoperative Nausea and Vomiting | Quality of Recovery

China
Penang Hospital, Malaysia

Unknown

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

End Stage Renal Failure | Anaemia
Penang Hospital, Malaysia

Completed

Efficacy of Azithromycin in Treatment of Bronchiectasis

Bronchiectasis

Malaysia
Penang Hospital, Malaysia

Completed

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

End Stage Renal Failure

Malaysia
Weifang Medical University

Not yet recruiting

Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer

Anxiety | Sleep Quality

China
Weifang Medical University

Recruiting

Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy

Postoperative Nausea and Vomiting

China
Penang Hospital, Malaysia

Recruiting

Immune Response of Haemodialysis Patients Post Covid-19 Vaccination (Covid-19)

Immune Response Post Covid 19 Vaccination

Malaysia
Penang Hospital, Malaysia

Completed

Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage (LEGA)

Chronic Obstructive Pulmonary Disease (COPD) | Chronic Bronchiectasis

Malaysia
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Beijing Kejing Biotechnology Co., Ltd.
Beijing Kejing Biotechnology Corp.

Withdrawn

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients (CCT-ANK-11)

Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Completed

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Shenzhen Kexing Pharmaceutical Co., Ltd.

Recruiting

A Phase I Study of SHEN26 Capsule in Healthy Participants

Healthy Participants

China
Kexing Biopharm Co., Ltd.

Recruiting

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Respiratory Syncytial Virus Infections

China
Kiang Wu Hospital

Completed

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Kiang Wu Hospital

Completed

Biomarkers to Predict the Response to Pembrolizumab in Chinese NSCLC Patients

NSCLC Stage IV

China
Zai Lab (Shanghai) Co., Ltd.
Zai Lab (US) LLC

Recruiting

An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer

SCLC

United States
Zai Lab (Hong Kong), Ltd.
Zai Lab (US) LLC

Not yet recruiting

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Plaque Psoriasis

Australia
Jiang Liu

Recruiting

Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery

Postoperative Nausea and Vomiting

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Platinum-sensitive Relapsed Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib

Gastrointestinal Stromal Tumor(GIST)

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Zai Lab Pty. Ltd.

Unknown

Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis

Australia
Kuang Tien General Hospital

Recruiting

The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic Migraine

Episodic Migraine

Taiwan
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Unresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous Melanoma

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Breast Cancer Metastatic

Taiwan
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Niraparib in Patients With Relapsed Ovarian Cancer

Ovarian Cancer

China
Sung Kwang Medical Foundation

Completed

Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy

Cerebral Palsy

Korea, Republic of
Kuang Tien General Hospital

Completed

Acupuncture in Patients With Carpal Tunnel Syndrome ~ A Randomized Controlled Trial

Carpal Tunnel Syndrome

Taiwan
Kuang Tien General Hospital

Recruiting

Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia

Sleep Disorder | CKD

Taiwan
Kuang Tien General Hospital

Recruiting

Acupuncture Versus Laser Acupuncture for Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Taiwan
Kuang Tien General Hospital

Completed

Alpha-s1 Casein Hydrolysate on Sleep

Chronic Insomnia | Polysomnography

Taiwan
Kuang Tien General Hospital

Completed

Omega-3 Fatty Acid in the Prevention of Migraine

Migraine | Omega-3 Polyunsaturated Fatty Acids

Taiwan
Kuang Tien General Hospital

Completed

Acupuncture in Chronic Migraine: A Randomized Controlled Trial

Patients With Chronic Migraine

Taiwan
Zai Lab Pty. Ltd.

Completed

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

Eczema

China
Zai Lab (Shanghai) Co., Ltd.

Completed

To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies

Solid Malignancies

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Trial of ZL-1201 in Subjects With Advanced Cancer

Advanced Cancer

United States, China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Gastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract Carcinoma

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC

HER2 Positive Metastatic Breast Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Hepatocellular Carcinoma (HCC)

China
Zai Lab (Shanghai) Co., Ltd.

Completed

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Ovarian Cancer

China

3

Subscribe